发明名称 SUBSTITUIERTE ARYLPYRAZINE
摘要 Arylpyrazine compounds are provided, including arylpyrazines that can bind with high affinity and high selectivity to CRF<SUB>1 </SUB>receptors, including human CRF<SUB>1 </SUB>receptors. The invention thus includes methods for treatment of disorders and diseases associated with CRF<SUB>1 </SUB>receptors, including CNS-related disorders and diseases, particularly affective disorders and diseases, and acute and chronic neurological disorders and diseases.
申请公布号 AT307121(T) 申请公布日期 2005.11.15
申请号 AT20010910939T 申请日期 2001.02.16
申请人 NEUROGEN CORPORATION 发明人 YOON, TAEYOUNG;GE, PING;HORVATH, RAYMOND, F.;DE LOMBAERT, STEPHANE;HODGETTS, KEVIN, J.;DOLLER, DARIO;ZHANG, CUNYU
分类号 A61K31/4965;A61K31/5377;A61P1/00;A61P1/04;A61P9/10;A61P9/12;A61P15/00;A61P19/10;A61P25/00;A61P25/18;A61P25/22;A61P25/24;A61P43/00;C07D241/00;C07D241/12;C07D241/18;C07D241/20;C07D401/04;C07D401/12;C07D403/04;C07D403/12;C07D405/12;C07D409/04 主分类号 A61K31/4965
代理机构 代理人
主权项
地址